A pair of new studies support the claim by many women that their migraine headaches are associated with their menstrual cycle, leading to the possibility new medicines can be timed with those cycles to deliver relief. One of the studies showed women were more than twice as likely to have migraines in the first three days of their cycle than on any other days; the other showed that women who took frovatriptan at the beginning of their cycles suffered fewer headaches than those on placebos.

Full Story:

Related Summaries